Strategic Partnerships Magnus is rapidly expanding its health system partnerships across 14 states with major facilities (Cleveland Clinic, UPMC, HCA, UTHealth, Houston Methodist, Dartmouth-Hitchcock, Sutter Health, OhioHealth and more), creating a growing footprint for SAINT adoption and scalable North American deployment opportunities for enterprise healthcare sales teams.

Clinical Validation SAINT has FDA breakthrough designation and 510(k) clearance for treating major depressive disorder, establishing a compelling clinical and regulatory foundation to address payer discussions, hospital procurement, and physician adoption in neuropsychiatric care.

Growing Demand With existing revenue in the multi‑tens of millions and a substantial funding runway, Magnus is well positioned to accelerate hospital and health system contracts, offering a scalable neuromodulation solution that can expand within large health networks seeking innovative mental health therapies.

Tech‑Forward Platform The tech stack leveraging cloud services, analytics, CRM and digital marketing indicates a modern, integrable platform ready for enterprise deployment, data capture, outcome tracking, and potential integration with hospital IT ecosystems to streamline procurement and ongoing support.

Expansion Momentum Continued 2026 launches across new locations and states imply recurring surface area for sales outreach, channel development, and clinical education initiatives, presenting recurring opportunities for regional account management, site champions, and payer negotiations.